Author:
Banks Robert O.,Pollock David M.,Novak Jacqueline
Reference100 articles.
1. Hickey, K. A., Rubanyi, G. M., Paul, R. J., and Highsmith, R. F. (1985) Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am. J. Physiol. 248: C550–0556.
2. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, K., Goto, Y., and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332: 411–415.
3. Goetz, K. L., Wang, B. C., Madwed, J. B., Zhu, J. L., and Leadley, R. J., Jr. (1988) Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Phyiol. 255: R1064 — R1068.
4. Simonson, M. S. and Dunn, M. J. (1993) Endothelin peptides and the kidney. Annu. Rev. Physiol. 55: 249–265.
5. Frelin, C. and Guedin, D. (1994) Why are circulating concentrations of endothelin-1 so low? Cardiovas. Res. 28: 1613–1622.